| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 66.88▲ | 66.59▲ | 66.71▲ | 66.31▲ | 68.13▼ |
| MA10 | 66.88▲ | 66.38▲ | 66.04▲ | 67.70▼ | 66.84▲ |
| MA20 | 66.55▲ | 65.70▲ | 65.03▲ | 67.42▼ | 70.50▼ |
| MA50 | 65.37▲ | 65.77▲ | 66.88▲ | 66.99▲ | 79.87▼ |
| MA100 | 65.02▲ | 67.34▼ | 68.05▼ | 72.45▼ | 68.29▼ |
| MA200 | 66.64▲ | 67.26▼ | 68.59▼ | 76.90▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.031▼ | 0.238▲ | 0.419▲ | -0.331▼ | N/A |
| RSI | 61.676▲ | 61.503▲ | 57.087▲ | 48.450▼ | N/A |
| STOCH | 62.811 | 81.325▲ | 89.908▲ | 32.010 | 67.797 |
| WILL %R | -15.961▲ | -8.551▲ | -7.436▲ | -47.632 | -43.698 |
| CCI | 72.541 | 102.019▲ | 108.320▲ | -68.664 | -41.436 |
|
Friday, February 22, 2019 05:21 AM
Today, Guggenheim initiated coverage on AnaptysBio Inc (NASDAQ:ANAB) with a Buy. There are 10 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current ...
|
|
Saturday, February 09, 2019 04:00 PM
Just how open is the IPO window for biotechs in 2017? After a solid start this year for life sciences offerings, two companies haven’t been able to get to market—the latest being Cambridge, MA-based V...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/02/19 | 66.28 | 67.415 | 65.82 | 67.17 | 208,472 |
| 21/02/19 | 65.00 | 65.98 | 63.99 | 64.94 | 164,200 |
| 20/02/19 | 66.04 | 66.50 | 61.42 | 65.03 | 451,149 |
| 19/02/19 | 69.05 | 69.05 | 65.54 | 66.05 | 233,875 |
| 15/02/19 | 69.50 | 70.365 | 68.175 | 68.35 | 259,489 |
| 14/02/19 | 67.86 | 69.36 | 67.10 | 69.20 | 187,806 |
| 13/02/19 | 69.73 | 70.01 | 67.56 | 67.85 | 217,982 |
| 12/02/19 | 70.82 | 71.89 | 68.83 | 69.34 | 220,951 |
| 11/02/19 | 69.43 | 70.18 | 68.44 | 70.14 | 230,916 |
| 08/02/19 | 69.53 | 70.47 | 68.01 | 68.89 | 181,517 |
|
|
||||
|
|
||||
|
|
||||
|
|